Karolinska Institutet
Solna, 17177, Sweden
NCT Number: NCT03826732
The efficacy of guided self-help based on acceptance and commitment therapy (ACT) to reduce subjective sense of stress will be investigated in a randomised controlled trial with two condition: 1) ACT-based self-help, and 2) Wait-list control. The outcome at the end of the treatment (week 10) and 6-month follow-up will be assessed. The wail-list condition will be offered ACT-based self-help after the post-assessment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Solna, 17177, Sweden
The efficacy of guided self-help based on acceptance and commitment therapy (ACT) to reduce subjective sense of stress will be investigated in a randomised controlled trial with two condition: 1) ACT-based self-help, and 2) Wait-list control. The outcome at the end of the treatment and 6-month follow-up will be assessed. The wail-list condition will be offered ACT-based self-help after 10 weeks (i.e. when the post-assessment is completed). Inclusion criteria are: Adults with a score above 14 on the stress sub scale of the Depression, Anxiety, Stress Scale (DASS) at screening, a score below 10 on the Patient Health Questionnaire (PHQ-9), no indication of suicidality on the PHQ-9, and no ongoing psychotherapeutic interventions, and no previous work with the self-help manual that has been published as a self-help book.
A total of 140 participants will be recruited and randomised, using services on www.random.org. Informed consent will be obtained from all the participants ahead of screening. Participants will be asked to respond to the following questionnaires at pre-, post and follow-up assessments: Perceived Stress Scale-14 (PSS-14), General Anxiety Disorder-7 (GAD-7), Shirom Melamed Burnout Measure (SMBM), and Brunnsviken Brief Quality of Life Inventory (BBQ). Initially, they will also be asked to respond to the credibility/Expectancy Questionnaire (CEQ).
At the end of the intervention (week 10), participants will also be asked to respond to the Client Satisfaction Questionnaire (CSQ), and the Negative Effects Questionnaire (NEQ).
The following two scales will be used to study mediators: Acceptance and Action Questionnaire-2 (AAQ-2), and Attention Awareness Scale (MAAS), assess at pre-treatment, as well as at third and fifth week of treatment, at post-assessment (10 weeks later), and at the 6 months follow-up. A number of moderators, including demographics, will also be investigated.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ACT-based self-help book and regular support by trained facilitators
Time frame: Pre-assessment, week 3 and 5 of intervention, post-assessment (week10), and 6 months follow-up
The PSS-14 is measure of stress. Its total score ranges from 0-56. Lower values represent a better outcome.
Time frame: Pre- and post-assessment (10 weeks later) as well as 6 months follow-up
The PHQ-9 provides a measure of depressive symptomatology. It ranges from 0-27. Lower values represent a better outcome
Time frame: Pre- and post-assessment (10 weeks later) as well as 6 months follow-up
The GAD-7 is used to measure anxiety. It ranges from 0-21. Lower values represent a better outcome.
Time frame: Pre- and post-assessment (10 weeks later) as well as 6 months follow-up
The BBQ is a Swedish measure of quality of life. It ranges from 0-96. Higher values represent a better outcome.
Time frame: Pre- and post-assessment (10 weeks later) as well as 6 months follow-up
The SMBM provides a measure of burn-out. It has three sub-scales: 1) physical exhaustion, 2) cognitive fatigue, and 3) emotional exhaustion. The subscales are combined to compute a total score by summing the mean of the subscales. Scale ranges from 3-15. Higher values represent a better outcome.
Time frame: Pre-assessment, week 3 and 5 of intervention, post-assessment (week10), and 6 months follow-up
To Measure psychological flexibility (mediator of change). It ranges from 7-49. Lower values represent a better outcome.
Time frame: Pre-assessment, week 3 and 5 of intervention, post-assessment (week10), and 6 months follow-up
To measure mindfulness (potential mediator of change). The score is computed by the mean of the 15 items and the resulting scale ranges from 1-6. Higher values represent a better outcome.
Time frame: Post-assessment, and 6 month follow-up
To measure satisfaction and dissatisfaction with the intervention. It ranges from 8-32. Higher values indicate higher satisfaction.
Time frame: Post-assessment, and 6 month follow-up
To identify iatrogenic events. It ranges from 0-128. Lower values represent a better outcome (i.e. fewer negative effects from the intervention).
Time frame: Pre-assessment
To measure the perceived credibility of the intervention as well as expectations. It has two subscales; 1) expectancy, and 2) credibility. The individual items are first standardized and then summed up in each subscale. Higher values represent a better outcome.
Karolinska Institutet
Other
Guided Self-help Based on Acceptance and Commitment Therapy to Reduce Perceived Stress
Acronym: ACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07738848
Laparoscopic Surgery Simulation, Mental Workload
Kubang Kerian, Kelantan, Malaysia
View Trial DetailsNCT05438446
Anxiety, Anxiety Disorders
Athens, Attica, Greece
View Trial DetailsNCT07737366
Anxiety, Anxiety Disorders
Sakarya, Turkey (Türkiye)
View Trial DetailsNCT00787423
Chemically-Induced Disorders, Drug Abuse
Baltimore, Maryland, United States
View Trial Details